Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

Circulation

Volumn 96, Issue 2, 1997, Pages 404-407

  Gupta, Sandeep ^a,b   Leatham, Edward W ^a   Carrington, David ^a   Mendall, Michael A ^a   Kaski, Juan Carlos ^a   Camm, A John ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antibodies; Azithromycin; Chlamydia pneumoniae; Myocardial infarction

Indexed keywords

AZITHROMYCIN; BACTERIUM ANTIBODY;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIBIOTIC THERAPY; ANTIBODY TITER; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL;

EID: 0030803032     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.2.404     Document Type: Article

References (20)

1. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
2. Saikku P, Leinonen M, Mattila KJ, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2: 983-986.
3. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 1992;268:68-72.
4. Mendall MA, Carrington D, Strachan DP, Patel P, Molineaux N, Levy J, Toosey T, Camm AJ, Northfield TC. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 1995;30:121-128.
5. Saikku P, Leiononen M, Tenkanen L, Linnanmaki E, Ekman MR, Manniven V, Mantarri M, Frick MH, Huttenen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992;116: 273-277.
6. Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841-849.
7. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:1555-1561.
8. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med. 1991;91(suppl 3A);342:453-456.
9. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother. 1990;25(suppl A):73-82.
10. Rizzato G, Montemurro L, Fraioli P, Montanan G, Fanti D, Pozzoli R, Magliano E. Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia. Eur Respir J. 1995;8:398-402.
11. Bailey RL, Arullendran P, Whittle HC, Mabey DCW. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342:453-456.
12. Gupta S, Leatham EW, Carrington D, Mendall MA, Ireson N, Tooze J, Bevan D, Kaski JC, Camm AJ. The effect of azithromycin in post-myocardial infarction patients with elevated Chlamydia pneumoniae antibody titres. J Am Coll Cardiol. 1997;755-2. Abstract.
13. Gupta S, Carrington D, Leatham EW, Ireson N, Wong H, Mendall MA, Patel P, Camm AJ, Kaski JC. Chronic Chlamydia pneumoniae infection in post-myocardial infarction patients. Eur Heart J. 1996;2367. Abstract.
14. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, Wick G. Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Lancet. 1993; 341:255-259.
15. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham EW, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995;311:711-714.
16. Patel P, Carrington D, Strachan DP, Leatham EW, Goggin P, Northfield TC, Mendall MA. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet. 1994;343:1634-1635.
17. Leatham EW, Bath PM, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 1995;73: 10-13.
18. Holland MJ, Bailey RL, Ward ME, Morrison R, Whittle HC, Mabey DC. Cell mediated immune responses to Chlamydia trachomatis in scarring trachoma. Proc Eur Soc Chlam Res. 1992;2:134.
19. Campbell LA, O'Brien ER, Cappuccio AL, Kuo C-C, Wang S-P, Stewart D, Patton DL, Cummings PK, Grayston JT. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 1995;172:585-588.
20. Melnick SL, Shahar E, Folson AR, Grayston JT, Sorlie PD, Wang S-P, Szklo M. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med. 1993; 95:499-504.